An interventional study of Physical rehabilitation of gait with motor imagery and Physical rehabilitation of gait without motor imagery in Parkinson Disease, sponsored by University of Valencia. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-15.
Sponsored by University of Valencia · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 225 studies in Parkinson Disease with a site in Spain — 37 open to participants now, 56 under way, 3 of them phase 3. Parkinson Disease · Spain.
Among the 225 studies in Parkinson Disease with a site in Spain, this one is the 104th largest by planned enrollment of the 179 interventional ones that give a count, is one of 12 that started in 2025, is one of 68 with no phase, reaches primary completion later than 29 of the 55 other live ones, and was the 145th registered.
4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.
Browse Parkinson Disease studies →37 of the 225 studies in Parkinson Disease with a site in Spain are open now. Recruiting first, the newest first:
University of Valencia · Sites in Spain
Ages 18–99
University Hospital Tuebingen · Sites in Spain, France, Germany and 4 more countries
Ages 35–80
Universidad San Jorge · Sites in Spain
Ages 55–90
AbbVie · Sites in Spain, United States, Canada and 6 more countries
Ages 18–69
University of Vigo · Sites in Spain
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
225 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 38 · Phase 3 54 · Phase 4 12
First in 2002; this study’s year is marked. 12 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 74 is above the median of 40 across 3,360 interventional studies indexed under Parkinson Disease.
Median enrollment 100 across the 179 interventional studies, 300 across the 45 observational. Of the 153 that completed or were terminated, 60 (39%) have results posted.
This tab as a report to print or save as PDF → With an account.
131 of 225 have an industry lead sponsor. The 10 most frequent:
University of Valencia is the lead sponsor of 357 studies on the registry; 75 are open to participants now.
University of Valencia has 7 studies filed under Parkinson Disease — fewer than ten, so there is no comparison to draw.
13 of the studies in Parkinson Disease with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07780461University of VigoCharacterization and Validation of the Short Physical Performance Battery in Individuals Diagnosed With Parkinson's Disease | 2026-11-25 |
| NCT04788693University of ValenciaEffects of Gait Rehabilitation With Motor Imagery in People With Parkinson's Disease | 2026-12 |
| NCT07842926Universidad San JorgeAcute Effects of Capacitive-Resistive Radiofrequency Therapy in People With Parkinson's Disease | 2026-12-01 |
| NCT01799915NYU Langone HealthNatural History Study of Synucleinopathies | 2026-12-30 |
| NCT07284342AbbVieA Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receiving Subcutaneous Foslevodopa/Foscarbidopa | 2027-01 |
Add all 13 to your calendar (.ics) → With an account.
Among the 225 studies in Parkinson Disease with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to determine whether gait physiotherapy combined with motor imagery exercises has a superior effect than gait physiotherapy without motor imagery in people with Parkinson's disease. To do this, a six-week training program will be carried out twice a week, where walking exercises and motor imaging will be performed in the experimental group while walking exercises only, will be conducted in the control group. Motor imagery exercises consist of developing a mental exercise by which an individual rehearses or simulates a given action. We hypothesize that participants who perform motor imagery exercises have better results than participants who train without imagery exercises. To analyze the effect of the programs will be assess the gait, the functionality in activities of daily living, the motor capacity, and the perception of the quality of life of the participants.
Background:
Motor imagery (MI) is a novel technique in neurorehabilitation. Current evidence supports the ability of people diagnosed with Parkinson's disease (PD) to carry out this technique. However, the trials that assess its effectiveness in this pathology are scarce. In some physical rehabilitation programs, MI is introduced to conventional treatment or, MI can be combined with observation of images or neurofeedback. At present, the effect of this technique has been studied in highly heterogeneous variables, including both motor and cognitive abilities or performance of activities of daily living. The evidence seems to indicate that the introduction of MI to conventional treatment, with an adequate dose, may induce greater benefits over people with PD in early stages (I-III on the Hoehn and Yahr scale), especially in daily actions and movements functional such as gait, regardless of medication. However, the small sample size of the trials and the use of non-validated scales and non-objective tests, make it necessary that the results be viewed with caution. On the other hand, the cost-benefit ratio of the therapy, its benefits and its easy application are significant factors to take into account when adding MI to physiotherapy treatment in people with PD.
General objective: To determine whether gait training combined with MI exercises has a superior effect on gait, functionality in activities of daily living, motor capacity, and the perception of the quality of life in people with PD, which gait training without MI.
Specific objectives:
Materials and Method:
The evaluation session will be carried out three times: before the treatment, at the end of the intervention, and 8-weeks after the intervention has finished. In each evaluation session, a clinical and biomechanical measurement will be carried out. The biomechanical evaluation will be done using 7 inertial sensors in a 10-meter walk corridor. The inertial sensor or inertial measurement unit (IMU) is made up of three different sensors: gyroscope, accelerometer, and magnetometer, capable of collecting information on the turns, linear acceleration, and magnetic north with respect to the earth's magnetic field. The part of the clinical evaluation includes the assessment of the functionality in the activities of daily living, the motor capacity, and the perception of the quality of life through different questionnaires and assessment scales.
Intervention:
Both, the experimental and control groups of this study, will perform an identical gait physiotherapy program, however, motor imagery exercises will be included in the experimental group.
The gait exercises are aimed at improving specific gait characteristics, so they will include:
The motor imagery exercises will be performed in supine position on a stretcher, before each gait exercise. The instructions will be administered through the physiotherapy voice. The participant with closed eyes imagines himself performing the gait task while the general guidelines that guide the cognitive process are given. The instructions describe how the person is from the starting position and the different body movements that he must pay attention to during the imagining process. Through the instructions, the participant creates an image of himself and perceives the kinesthesia while performing the exercise. The duration of each motor imagery exercise is 8 minutes.
The inclusion criteria are:
Likewise, the exclusion criteria are:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Gait training twice a week for six weeks. Each rehabilitation session is composed of an initial 5 minutes of warm-up exercises (general mobility, coordination, strength, flexibility, balance, and breathing), followed by 45 minutes of gait training with motor imagery exercises and a final 10 minutes of muscle stretching. In the central 45 minutes of the session, exercises will be developed to improve objective characteristics of the gait-related to spatiotemporal and kinematic parameters. Objective and subjective feedback will be used for each exercise (cues). In an interspersed way, motor imagery exercises will be carried out where participants must rehearse or simulate mentally each gait exercise that will be developed in the session.
Other: Physical rehabilitation of gait with motor imagery
Gait training twice a week for six weeks. Each rehabilitation session is composed of an initial 5 minutes of warm-up exercises (general mobility, coordination, strength, flexibility, balance, and breathing), followed by 45 minutes of gait training with motor imagery exercises and a final 10 minutes of muscle stretching. In the central 45 minutes of the session, exercises will be developed to improve objective characteristics of the gait-related to spatiotemporal and kinematic parameters. Objective and subjective feedback will be used for each exercise (cues). In the periods that the experimental group performs the motor imagery exercises, the control group will take breaks.
Other: Physical rehabilitation of gait without motor imagery
Physical rehabilitation of gait is a type of non-invasive treatment that seeks to change the way of performing a task or motor function (in this case, gait) through movement modification and corrected repeated practice, taking into account the alterations, limitations and considerations related to the disease suffered by the person. In this intervention, in addition to physical exercise to correct gait, mental exercises will be included in which the patient visualizes himself performing the exercises that he will then develop with the body.
Also known as: GAITimagery program
Physical rehabilitation of gait is a type of non-invasive treatment that seeks to change the way of performing a task or motor function (in this case, gait) through movement modification and corrected repeated practice, taking into account the alterations, limitations and considerations related to the disease suffered by the person. Motor imagery exercises are not included in this program.
Also known as: Gait physiotherapy program
Gait velocity at the post-training time (primary time point)
Distance traveled by the body per unit of time at self-selected or comfortable speed, in the direction considered. It is expressed in meters per second (m / s).
Time frame: 6 weeks
Gait speed variability
It is calculated through the coefficient of variation (\[standard deviation/mean\] × 100) of gait velocity. Indicates how stable or repeatable the participants are when walking.
Time frame: 6 weeks
Maximum gait speed
Distance traveled by the body per unit of time at the maximum possible speed, in the direction considered. It is expressed in meters per second (m/s).
Time frame: 6 weeks
Stance time
Time elapsed while the support or stance phase of the gait cycle is developed. It is expressed as a percentage of the total walking cycle and additionally in seconds.
Time frame: 6 weeks
Weight-acceptance Ground Reaction Force (Newton, N; Weight%)
Kinetic outcome; First force peak of vertical vector of the ground reaction forces during the stance phase of the gait cycle, which corresponds to the maximum reception of weight on the foot that initiates the gait cycle.
Time frame: 6 weeks
Midstance Ground Reaction Force (Newton, N; Weight%)
Kinetic outcome; Lowest force point of the valley located between both maximum force peaks of the vertical vector of the ground reaction forces, which corresponds to the swing of the opposite leg during the gait cycle.
Time frame: 6 weeks
Push-off Ground Reaction Force (Newton, N; Weight%)
Kinetic outcome; Second and last force peak of the vertical vector of the ground reaction forces during the stance phase of the gait cycle, which corresponds to the beginning of takeoff of the foot during the last part of the stance phase.
Time frame: 6 weeks
Breaking Ground Reaction Force (Newton, N; Weight%)
Kinetic outcome; First maximum force peak of the antero-posterior vector of the ground reaction forces during the gait cycle that corresponds to the braking of the foot on the ground.
Time frame: 6 weeks
Propulsion Ground Reaction Force (Newton, N; Weight%)
Kinetic outcome; Second maximum force peak of the antero-posterior vector of the ground reaction forces during the gait cycle that corresponds to the propulsion of the foot on the ground at the end of the stance phase.
Time frame: 6 weeks
Cadence (steps/min)
Number of steps executed in a time interval, its most commonly adopted unit being the step per minute.
Time frame: 6 weeks
Stride length
Distance measured between two consecutive supports points of the same foot; the heel strike is the reference used. It is expressed in meters (m).
Time frame: 6 weeks
Step length
The distance measured between one foot's heel contact and the other's heel contact. It is expressed in meters (m).
Time frame: 6 weeks
Swing time
Time elapsed while the swing phase develops. It is expressed as a percentage according to the entire walking cycle and additionally in seconds.
Time frame: 6 weeks
Double support time
Time that both feet are in contact with the ground during the gait cycle. It is expressed in seconds (s) and also as a percentage (%) of the total gait cycle.
Time frame: 6 weeks
Range of motion of lower limb joint (°)
Kinematic outcome that represents the range of motion in the sagittal plane of the hip, knee, and ankle joints performed during the gait cycle. These parameters will be specified for each limb (right and left).
Time frame: 6 weeks
Maximum ankle dorsiflexion during swing (°)
Kinematic outcome; Maximum ankle dorsiflexion angle reached during the swing phase, expressed in degrees.
Time frame: 6 weeks
Maximum knee flexion during swing (°)
Kinematic outcome; Maximum knee flexion angle reached during the swing phase, expressed in degrees.
Time frame: 6 weeks
Maximum hip extension during stance (°)
Kinematic outcome; Maximum hip extension angle reached during the stance phase, expressed in degrees.
Time frame: 6 weeks
Maximum hip flexion during swing (°)
Kinematic outcome; Maximum hip flexion angle reached during the swing phase, expressed in degrees.
Time frame: 6 weeks
Activities of daily life
Self-referred Quality of Life measured with the Schwab \& England scale score.
Time frame: 6 weeks
Quality of Life perceived
Self-referred quality of life measured with the Parkinson's Disease Questionnaire-39 score questionnaire.
Time frame: 6 weeks
Freezing of gait
Freezing of gait Questionnaire score
Time frame: 6 weeks
Gait qualitative performance with TMT
Tinetti mobility test - Gait section score
Time frame: 6 weeks
Gait qualitative performance with DYPAGS
Dynamic Parkinson Gait Scale score
Time frame: 6 weeks
Balance qualitative performance with the TMT
Tinetti mobility test - Balance section score
Time frame: 6 weeks
Balance qualitative performance with the MiniBest
MiniBest test score
Time frame: 6 weeks
Mobility
Time taken to perform Timed-up and go test (s)
Time frame: 6 weeks
Plan to share: No — All measured and recorded data will be shared through the publications made and through their supplementary material.
Start is estimated for Sep 2025; primary completion for Dec 2026, 15 months later.
Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 15 months is below that.
Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.